Cite

HARVARD Citation

    Quintana, R. et al. (2017). Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion. Sarcoma. p. . [Online]. 
  
Back to record